FOSUN PHARMA announced that the controlling shareholder FOSUN High Technology pledged 0.198 billion A-shares to the Industrial And Commercial Bank Of China Shanghai Changning Branch on December 20, accounting for 7.41% of the company's total share capital, with the pledge period until December 23, 2026, for the purpose of repaying debts. After the pledge, FOSUN High Technology has pledged a total of 0.7118 billion shares of FOSUN PHARMA, accounting for 26.65% of the company's total share capital.As of December 20, FOSUN High Technology and its concerted action parties collectively hold 0.968 billion shares of FOSUN PHARMA, accounting for 36.23% of the company’s total share capital. After this pledge, the number of pledged shares by FOSUN High Technology and its concerted action parties is 0.7118 billion shares...Show More

FOSUN PHARMA announced that the controlling shareholder FOSUN High Technology pledged 0.198 billion A-shares to the Industrial And Commercial Bank Of China Shanghai Changning Branch on December 20, accounting for 7.41% of the company's total share capital, with the pledge period until December 23, 2026, for the purpose of repaying debts. After the pledge, FOSUN High Technology has pledged a total of 0.7118 billion shares of FOSUN PHARMA, accounting for 26.65% of the company's total share capital.As of December 20, FOSUN High Technology and its concerted action parties collectively hold 0.968 billion shares of FOSUN PHARMA, accounting for 36.23% of the company’s total share capital. After this pledge, the number of pledged shares by FOSUN High Technology and its concerted action parties is 0.7118 billion shares, accounting for 73.55% of the shares they hold in the company. Among them, 0.433 billion pledged shares are set to expire within the next year, corresponding to a financing balance of 4.36 billion yuan; 0.296 billion shares will expire within the next six months, corresponding to a financing balance of 2.926 billion yuan.FOSUN PHARMA stated that the controlling shareholder's production and operation are normal, and it possesses the financial capability to repay. The sources of repayment funds include issuing bonds, dividends, and investment exits. The company claimed that the existing share pledges by the controlling shareholder will not adversely affect the group's main business, continuous operation capability, or corporate governance, nor will it result in any change in the company's actual control.